GET THE LATEST FROM MYDAYIS
Want to know more? Sign up for Mydayis (mixed salts of a single-entity amphetamine product) news and ADHD information that you can check out at your leisure.
For ADHD in patients 13 years and older. Not for children 12 years and younger.
Abuse and dependence. Mydayis, other amphetamine containing medicines, and methylphenidate have a high chance for abuse and can cause physical and psychological dependence. Your healthcare provider should check you or your child for signs of abuse and dependence before and during treatment with Mydayis.
Mydayis is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. Keep Mydayis in a safe place to protect it from theft. Never give Mydayis to anyone else, because it may cause death or harm them. Selling or giving away Mydayis may harm others and is against the law. MORE IMPORTANT SAFETY INFORMATION
Want to know more? Sign up for Mydayis (mixed salts of a single-entity amphetamine product) news and ADHD information that you can check out at your leisure.
Abuse and dependence. Mydayis, other amphetamine containing medicines, and methylphenidate have a high chance for abuse and can cause physical and psychological dependence. Your healthcare provider should check you or your child for signs of abuse and dependence before and during treatment with Mydayis.
Tell your healthcare provider (HCP) if you or your child have ever abused or been dependent on alcohol, prescription medicines, or street drugs. Your HCP can tell you how physical and psychological dependence and drug addiction are different.
Mydayis is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. Keep Mydayis in a safe place to protect it from theft. Never give Mydayis to anyone else, because it may cause death or harm them. Selling or giving away Mydayis may harm others and is against the law.
Read additional Important Safety Information ⟫
Continue to the SiteAbuse and dependence. Mydayis, other amphetamine containing medicines, and methylphenidate have a high chance for abuse and can cause physical and psychological dependence. Your healthcare provider should check you or your child for signs of abuse and dependence before and during treatment with Mydayis.
Tell your healthcare provider (HCP) if you or your child have ever abused or been dependent on alcohol, prescription medicines, or street drugs. Your HCP can tell you how physical and psychological dependence and drug addiction are different.
Mydayis is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. Keep Mydayis in a safe place to protect it from theft. Never give Mydayis to anyone else, because it may cause death or harm them. Selling or giving away Mydayis may harm others and is against the law.
Who should not take Mydayis?
Do not take Mydayis if you or your child is:
Serious problems can occur while taking Mydayis. Tell your HCP:
What should I avoid during Mydayis treatment?
What are possible side effects of Mydayis?
The most common side effects of Mydayis include:
What is MYDAYIS®?
Mydayis (mixed salts of a single-entity amphetamine product) is a prescription medicine for ADHD in patients 13 years and older. Mydayis is not for children 12 years and younger.
For additional safety information, click for Medication Guide, including Warning about Abuse, and discuss with your healthcare provider.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Takeda is committed to helping ensure the proper use of stimulant medication. Please see the Proper Use of Prescription Stimulant Medication for additional information.
There is a pregnancy registry for females who are exposed to MYDAYIS during pregnancy. The purpose of the registry is to collect information about the health of females exposed to MYDAYIS and their babies. If you or your child becomes pregnant during treatment with MYDAYIS, talk to your healthcare provider about registering with the National Pregnancy Registry for Psychiatric Medications at 1-866-961-2388 or visit online at https://womensmentalhealth.org/research/pregnancyregistry/.